What are smart ways boards can identify and negotiate opportunities to save money?

The many fees and expenses associated with running any company are more than just a headache. Particularly for R&D‑intensive biotech companies, failing to stay on top of them can significantly saddle a company with unnecessary cash burn. A new video resource at RA Capital’s free Gateway platform for boards and biotech leadership features industry leaders sharing their experiences navigating these pesky financial challenges.

How can you save money on ATM fees? What’s the best way to drive down costs of D&O insurance? When you’re doing a financing, when are banks necessary, and when can you do without them (and their impact on your bottom line)? Can you think of other ways development-stage biotechs can save money to redirect it toward R&D? Let us know!

Featuring:

• Peter Kolchinsky, Managing Partner, RA Capital Management
• Paul Hastings, President & CEO, Nkarta Therapeutics
• Adam Simpson, CEO, Icosavax
• Lynne Sullivan, CFO & Head of Corporate Dev, Unity Biotechnology
• William Collins, Partner, Goodwin Procter
• Sarah Reed, General Counsel, RA Capital Management

Watch the trailer below and click here to view the full video on Gateway, RA Capital’s hub for biotech boards and leadership.